The Role and Potential of <sup>18</sup>F-FDG PET/CT in Malignant Melanoma: Prognostication, Monitoring Response to Targeted and Immunotherapy, and Radiomics

Novel therapeutic approaches, consisting of immune check-point inhibitors (ICIs) and molecularly targeted therapy, have thoroughly changed the clinical management of malignant melanoma (MM), the most frequent and deadly skin cancer. Since only 30–40% of MM patients respond to ICIs, imaging biomarker...

Full description

Bibliographic Details
Main Authors: Luca Filippi, Francesco Bianconi, Orazio Schillaci, Angela Spanu, Barbara Palumbo
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/4/929